This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Jul;27(3):446-447.

doi: 10.3350/cmh.2021.0133. Epub 2021 May 21.

An analysis of polygenic risk scores for non-alcoholic fatty liver disease

Affiliations

PMID: 34024056
PMCID: PMC8273633
DOI: 10.3350/cmh.2021.0133

Editorial

An analysis of polygenic risk scores for non-alcoholic fatty liver disease

Dae Won Jun. Clin Mol Hepatol. 2021 Jul.

. 2021 Jul;27(3):446-447.

doi: 10.3350/cmh.2021.0133. Epub 2021 May 21.

Author

Affiliation

¹ Department of Internal Medicine, College of Medicine, Hanyang University, Seoul, Korea.

PMID: 34024056
PMCID: PMC8273633
DOI: 10.3350/cmh.2021.0133

No abstract available

Keywords: Genes; Non-alcoholic fatty liver disease; Polymorphism, Single nucleotide.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has no conflicts to disclose.

Comment on

Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort.
Ting YW, Kong AS, Zain SM, Chan WK, Tan HL, Mohamed Z, Pung YF, Mohamed R. Ting YW, et al. Clin Mol Hepatol. 2021 Jul;27(3):486-498. doi: 10.3350/cmh.2020.0162. Epub 2021 Feb 23. Clin Mol Hepatol. 2021. PMID: 33618508 Free PMC article.

Similar articles

Association of genetic variants with non-alcoholic fatty liver disease in an urban Sri Lankan community.
Kasturiratne A, Akiyama K, Niriella MA, Takeuchi F, Isono M, Dassanayake AS, de Silva AP, Wickremasinghe RA, Kato N, de Silva HJ. Kasturiratne A, et al. Liver Int. 2015 Feb;35(2):676-9. doi: 10.1111/liv.12624. Epub 2014 Jul 10. Liver Int. 2015. PMID: 24947803 No abstract available.
Clinical utility of polygenic risk scores for predicting NAFLD disorders.
Dessein A. Dessein A. J Hepatol. 2021 Apr;74(4):769-770. doi: 10.1016/j.jhep.2021.02.005. Epub 2021 Feb 27. J Hepatol. 2021. PMID: 33653592 No abstract available.
Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children.
Zusi C, Morandi A, Maguolo A, Corradi M, Costantini S, Mosca A, Crudele A, Mantovani A, Alisi A, Miraglia Del Giudice E, Targher G, Maffeis C. Zusi C, et al. Nutr Metab Cardiovasc Dis. 2021 May 6;31(5):1548-1555. doi: 10.1016/j.numecd.2021.01.020. Epub 2021 Feb 4. Nutr Metab Cardiovasc Dis. 2021. PMID: 33810963
Genetic predisposition in nonalcoholic fatty liver disease.
Sookoian S, Pirola CJ. Sookoian S, et al. Clin Mol Hepatol. 2017 Mar;23(1):1-12. doi: 10.3350/cmh.2016.0109. Epub 2017 Mar 9. Clin Mol Hepatol. 2017. PMID: 28268262 Free PMC article. Review.
Genetics and epigenetics of NAFLD and NASH: Clinical impact.
Eslam M, Valenti L, Romeo S. Eslam M, et al. J Hepatol. 2018 Feb;68(2):268-279. doi: 10.1016/j.jhep.2017.09.003. Epub 2017 Nov 6. J Hepatol. 2018. PMID: 29122391 Review.

See all similar articles

Cited by

Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response.
Sookoian S, Pirola CJ. Sookoian S, et al. Clin Mol Hepatol. 2023 Feb;29(Suppl):S184-S195. doi: 10.3350/cmh.2022.0318. Epub 2022 Dec 5. Clin Mol Hepatol. 2023. PMID: 36472053 Free PMC article. Review.
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology.
Yoon EL, Jun DW. Yoon EL, et al. Clin Mol Hepatol. 2023 Apr;29(2):371-373. doi: 10.3350/cmh.2023.0086. Epub 2023 Mar 14. Clin Mol Hepatol. 2023. PMID: 36916169 Free PMC article. No abstract available.
Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future.
Yu JH, Lee HA, Kim SU. Yu JH, et al. Clin Mol Hepatol. 2023 Feb;29(Suppl):S136-S149. doi: 10.3350/cmh.2022.0436. Epub 2022 Dec 12. Clin Mol Hepatol. 2023. PMID: 36503205 Free PMC article. Review.
Advances in genetic variation in metabolism-related fatty liver disease.
Shi F, Zhao M, Zheng S, Zheng L, Wang H. Shi F, et al. Front Genet. 2023 Sep 11;14:1213916. doi: 10.3389/fgene.2023.1213916. eCollection 2023. Front Genet. 2023. PMID: 37753315 Free PMC article. Review.
Risk factors in nonalcoholic fatty liver disease.
Ko E, Yoon EL, Jun DW. Ko E, et al. Clin Mol Hepatol. 2023 Feb;29(Suppl):S79-S85. doi: 10.3350/cmh.2022.0398. Epub 2022 Dec 14. Clin Mol Hepatol. 2023. PMID: 36517003 Free PMC article. Review.

References

1. Ting YW, Kong AS, Zain SM, Chan WK, Tan HL, Mohamed Z, et al. Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: results from a multi-ethnic Asian cohort. Clin Mol Hepatol. 2021 Feb 23; doi: 10.3350/cmh.2020.0162. - DOI - PMC - PubMed
1. Gellert-Kristensen H, Richardson TG, Davey Smith G, Nordestgaard BG, Tybjaerg-Hansen A, Stender S. Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population. Hepatology. 2020;72:845–856. - PubMed
1. Koo BK, Joo SK, Kim D, Lee S, Bae JM, Park JH, et al. Development and validation of a scoring system, based on genetic and clinical factors, to determine risk of steatohepatitis in Asian patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2020;18:2592–2599.e10. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information